Board Name | Posts By fingermoney | Post Created |
---|---|---|
FITX Creative Edge Nutrition Inc. | Tomorrow at noon?? | 03/09/2014 11:45:37 AM |
FITX Creative Edge Nutrition Inc. | They advertised 8.99 subscription f | 03/09/2014 11:43:40 AM |
FITX Creative Edge Nutrition Inc. | I had a 1 post per day restriction | 03/09/2014 11:36:23 AM |
FITX Creative Edge Nutrition Inc. | I'm still kicking myself in the but | 03/09/2014 11:34:54 AM |
FITX Creative Edge Nutrition Inc. | Yes, I am so glad I found this site | 03/09/2014 11:32:07 AM |
FITX Creative Edge Nutrition Inc. | Yeah I'm running on 4 hours of slee | 03/09/2014 11:22:48 AM |
PHOT Growlife Inc. | I think we will go up a little this | 03/09/2014 11:20:27 AM |
FITX Creative Edge Nutrition Inc. | I cannot wait till Monday. Going to | 03/09/2014 11:18:46 AM |
FITX Creative Edge Nutrition Inc. | There has been many misinformation | 03/09/2014 11:05:55 AM |
FITX Creative Edge Nutrition Inc. | deleted. | 03/08/2014 9:43:28 PM |
Recent Articles
- Investigating Alto Neuroscience: Investor Claims and Updates
- AquaBounty Technologies' Astounding After-Hours Stock Surge
- Fangzhou Shines as Leading Innovator in Healthcare Technology
- Investigation Launched by Faruqi & Faruqi on Fiserv Losses
- Insights on Cracker Barrel, D-Wave, IonQ, Krispy Kreme & Broadcom
- Louisville Vegan Jerky Joins Forces with Louisville Brands
- Miami Seaquarium Remembers Bimini, Beloved 26-Year-Old Dolphin
- Harnessing Technology to Transform the Future of Elderly Care
- Savara Inc. Investors Encouraged to Explore Legal Options
- Wayfyndr Enhances Fan Experience with New Partnerships
- Investigation Launched into Quantum Corporation for Investors
- Understanding the Legal Landscape for V.F. Corporation Shareholders
- Meta Launches Cutting-Edge Smart Glasses for Tech Enthusiasts
- Investors Alert on Fluor Corporation Class Action Updates
- Neuronata-R® Shows Promise for ALS Patients at Global Congress
- Discover My Main AI INC's Upcoming Enhancements for Users
- Innovative Partnership: Xpore and Patagonia's Sustainable Journey
- Wayfyndr Unveils Enhanced Fan Engagement with New Partners
- FEMSA's New Leadership: A Vision for Strategic Growth
- Investors Rally for Replimune: An Opportunity for Recovery
- Cryptocurrency Market Insights: Rate Cuts and Price Predictions
- Exploring the EBSCO Scholarly Graph: A New Era for Research
- Innovative Collaboration for Autonomous Construction Tech
- FEMSA's New CEO: A Vision for Future Growth and Sustainability
- Flywire Investors: Legal Insights on Upcoming Claims and Deadlines
- Investigation Launched into PubMatic by Faruqi & Faruqi, LLP
- Cathie Wood's Investment Moves: Bullish Trends and Strategic Exits
- Garmin Collaborates with Meta to Enhance AI Glasses Performance
- EssilorLuxottica and Meta Unveil Next-Gen AI Glasses in 2025
- Chenghe Acquisition III Co. Successfully Completes IPO Raising $126.5 Million
- Investor Alert: Tronox Holdings Faces Legal Scrutiny
- New Investigations Open for SelectQuote Investors Amid Concerns
- CAIXA ECONÔMICA FEDERAL Sees Tremendous Growth in 2025
- Celebrating Upcoming Leaders in Emergency Nursing for 2025
- Revolutionizing M&A: Navatar Enhances Deal Management with AI
- Investigation of Nutex Health Inc. by Faruqi & Faruqi, LLP
- Investigation Launched for Lockheed Martin Investor Claims
- Fangzhou Inc. Celebrates Gilead Excellence Award Success
- Explore Top Kitchen Flooring Choices with Roman Keim
- Investigation Launched Into Semler Scientific Investor Claims
- Investors of Charter Communications Face Legal Investigation
- State Department's Censorship Practices Under Scrutiny
- Investigation into Unicycive Therapeutics Sparks Investor Interest
- Impressive Growth Report: CAIXA Economic Performance in 2025
- Chongqing Hosts Revolutionary Robotics Competition Showcasing AI Innovations
- Minute Media's Strategic Move: Acquiring VideoVerse's AI Technology
- Clinical Study Results of Telitacicept at Major Medical Meeting
- Celebrating a Decade of Conservation: Fat Bear Week 2025
- Zacatecas Silver Corp Secures $3.75M in Private Placement
- Investigation of Altimmune: What Investors Need to Know